People On The Move: HRA Pharma, Hofseth BioCare, UK CHM
Executive Summary
A round-up of the latest people moves in Europe's health and wellness markets: HRA Pharma's CEO David Wright steps down; Hofseth BioCare promotes Ødegård to lead the company; and the UK's Commission on Human Medicines appoints nine new members.
You may also be interested in...
People On The Move: Appointments At ANEFP, CHPA, Norgine, InfectoPharm, DSM
A round-up of the latest appointments in Europe's and the US health and wellness industries: Spain's ANEFP elects Martín as president; US CHPA appoints Parks as senior VP of regulatory and scientific affairs, Norgine hires HRA's Hilton to lead its consumer business; Infectopharm names Weleda's Ammendola as R&D head; and DSM-Firmenich makes management changes.
HRA Proposes OTC Norgestrel Birth Control
HRA has worked with Ibis Reproductive Health, which supports the Free the Pill advocacy group, to conduct research for a norgestrel switch NDA.
HRA Pharma Posts Big Rise As Key Brands Grow Double Digits
Paris-based HRA Pharma reported significant sales gains for its key consumer health brands in 2021, helping to lift group turnover by more than 25%. This is likely to be the last set of results posted by HRA as a standalone company with Perrigo optimistic its proposed acquisition of the firm will soon complete.